Zhongnan Medical Journal Press

Home Results

A total of 21 result was found. Results that relate to Type 2 diabetes mellitus

Effects of GLP-1RA therapy in patients with overweight, obese type 2 diabetes mellitus and coronary heart disease

Published on Journal of Mathematical Medicine 2023,36(2):144-149.
7593 times 1707 times

Si-Yuan XIE Zi-Qiang ZHU

Glucagon-like peptide-1 receptor agonist Type 2 diabetes mellitus Coronary heart disease Overweight Obesity Insulin sensitivity
Details
Rapid health technology assessment of dulaglutide for the treatment of type 2 diabetes mellitus

Published on Chinese Journal of Pharmacoepidemiology 2023,32(8):931-940.
7932 times 1788 times

Yuan YAO Fen-Li SU Xu SUN Shi-Yin FENG Fen XIONG Qing-Qun CAI

Dulaglutide Type 2 diabetes mellitus Rapid health technology assessment
Details
Study of the correlation between glycosylated hemoglobin level, insulin resistance index, complications and psychological control sources in type 2 diabetes patients

Published on Journal of Mathematical Medicine 2023,36(6):434-439.
9062 times 1647 times

Wen-Fang LI Jing XIN Xin-Feng HOU Ya-Fei SHEN Fei DENG

Type 2 diabetes mellitus Psychological control source Glycosylated hemoglobin Insulin resistance index Complication
Details
Risk factors and prediction model of ketosis tendency in patients with newly diagnosed type 2 diabetes mellitus

Published on Journal of Mathematical Medicine 2023,36(8):586-591.
7170 times 1709 times

Jia-Yao CAI Xue-Jiang GU Yu-Hui PENG

Type 2 diabetes mellitus Newly diagnosed Ketosis tendency Risk factor Prediction model
Details
Treatment strategy selection for T2DM patients poorly treated with basal insulin combined with oral hypoglycemic agents: umbrella review

Published on Chinese Journal of Pharmacoepidemiology 2023,32(11):1275-1284.
7414 times 1811 times

Ya-Ping NIU San-Bao CHAI Jing-Zi MA Meng ZHANG Zuo-Xiang LIU Shan-Shan WU Feng SUN

Basal insulin Oral hypoglycemic agents Type 2 diabetes mellitus Poor treatment effect Umbrella review
Details
Influences of dapagliflozin on blood pressure variability and left ventricular mass index in patients with type 2 diabetes mellitus and hypertension

Published on Frontiers in Pharmaceutical Sciences 2023,36(12):413-419.
7547 times 2042 times

Sa-Sa LI Bei-Bei YE Xin LIU Xia-Ling ZHU

Dapagliflozin Type 2 diabetes mellitus Hypertension Blood pressure variability Left ventricular mass index
Details
Pharmacoeconomic evaluation of glucagon-like peptide-1 receptor agonist combined with metformin in the treatment of type 2 diabetes mellitus

Published on Chinese Journal of Pharmacoepidemiology 2024,33(4):388-401.
10361 times 2440 times

YU Tian LIU Shaohua WEI Anhua GUO Jieru ZHANG Chengliang LIU Dong LIU Zhelong

Glucagon-like peptide-1 receptor agonist Metformin Type 2 diabetes mellitus Cost-utility Markov model Pharmacoeconomics
Details
Effect of Tanganjianwan combined with abdominal massage on glucose and lipid metabolism and inflammatory factors in patients of metformin treatment with obesity and type 2 diabetes mellitus

Published on Frontiers in Pharmaceutical Sciences 2024,27(4):595-602.
9443 times 2032 times

HU Lijuan WAN Jing ZHU Hao

Tanganjianwan Abdominal massage Obesity and type 2 diabetes mellitus Glucose and lipid metabolism Inflammatory factors
Details
Efficacy and safety of glucagon-like peptide 1 receptor agonists in the treatment of overweight or obese patients with type 2 diabetes: a Meta-analysis

Published on Chinese Journal of Pharmacoepidemiology 2024,33(5):519-538.
9167 times 1955 times

YU Tian LIU Shaohua WEI Anhua GUO Jieru ZHANG Chengliang LIU Dong LIU Zhelong

Glucagon-like peptide 1 receptor agonists Type 2 diabetes mellitus Obesity or overweight Efficacy Safety Meta-analysis Randomized controlled trial
Details
Clinical observation of omacycline in the treatment of type 2 diabetes mellitus complicated with community-acquired bacterial pneumonia

Published on Frontiers in Pharmaceutical Sciences 2024,27(5):796-801.
10564 times 1857 times

ZHAO Liting XIA Jing LIANG Jiamin GU Chao TAO Feng

Omacycline Type 2 diabetes mellitus Community-acquired bacterial pneumonia Clinical efficacy Advese reaction
Details
Ertugliflozin in the treatment of type 2 diabetes mellitus: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2024,33(7):778-789.
10718 times 1993 times

QIN Fang WU Kunrong LIU Chengyu LIU Daihua

Ertugliflozin Type 2 diabetes mellitus Efficacy Safety Cost-effectiveness Rapid health technology assessment
Details
The prevalence and influencing factors of carotid plaque complicated with type 2 diabetes mellitus: a Meta-analysis

Published on Journal of Mathematical Medicine 2025,38(1):39-50.
10199 times 1502 times

GUO Mengjia XIONG Yi TAO Silu YE Zixiang WU Dongmei

Type 2 diabetes mellitus Carotid plaque Prevalence Glycated hemoglobin Meta-analysis
Details
Dorzagliatin in the treatment of type 2 diabetes：a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2025,34(4):448-455.
12975 times 2843 times

LI Yujie ZHANG Wenjing YANG Hongxin GUO Hao

Dorzagliatin Type 2 diabetes mellitus Rapid health technology assessment Efficacy Safety Economy
Details
Identification of mitochondrial feature genes for type 2 diabetes mellitus based on bioinformatics and machine learning

Published on Journal of Mathematical Medicine 2025,38(4):237-247.
10494 times 1830 times

REN Jing LI Yuting LIU Xiaoqin MENG Xianglong

Type 2 diabetes mellitus Mitochondrial gene Bioinformatics Machine learning
Details
Mechanism of agiophyllum oligo saccharides in improving type 2 diabetes mellitus related liver injury based on proteomics method

Published on Frontiers in Pharmaceutical Sciences 2025,29(8):1261-1270.
4639 times 929 times

ZHANG Zihan ZHANG Xiaojie YANG Yuze YANG Tianshuo XING Dongyang MA Qianqian BAO Shuyin

Agiophyllum oligo saccharides Type 2 diabetes mellitus Liver injury Proteomics
Details